Your browser is no longer supported. Please, upgrade your browser.
GILD [NASD]
Gilead Sciences, Inc.
IndexS&P 500 P/E11.78 EPS (ttm)5.84 Insider Own0.10% Shs Outstand1.26B Perf Week-2.26%
Market Cap85.47B Forward P/E10.06 EPS next Y6.84 Insider Trans-1.14% Shs Float1.25B Perf Month-5.02%
Income7.39B PEG8.89 EPS next Q1.56 Inst Own82.50% Short Float1.70% Perf Quarter1.73%
Sales27.48B P/S3.11 EPS this Y-97.70% Inst Trans-0.12% Short Ratio2.80 Perf Half Y-0.13%
Book/sh17.09 P/B4.03 EPS next Y-15.74% ROA10.90% Target Price77.00 Perf Year3.21%
Cash/sh4.62 P/C14.90 EPS next 5Y1.32% ROE37.80% 52W Range61.39 - 74.12 Perf YTD-5.19%
Dividend2.84 P/FCF14.43 EPS past 5Y-61.80% ROI5.00% 52W High-7.99% Beta0.39
Dividend %4.13% Quick Ratio1.20 Sales past 5Y-5.40% Gross Margin80.50% 52W Low11.09% ATR1.29
Employees13600 Current Ratio1.40 Sales Q/Q12.80% Oper. Margin42.30% RSI (14)33.47 Volatility2.54% 1.66%
OptionableYes Debt/Eq1.29 EPS Q/Q619.40% Profit Margin26.90% Rel Volume1.31 Prev Close68.84
ShortableYes LT Debt/Eq1.17 EarningsFeb 01 AMC Payout47.70% Avg Volume7.61M Price68.20
Recom2.40 SMA20-4.35% SMA50-3.36% SMA200-1.05% Volume3,933,385 Change-0.93%
Jan-06-22Downgrade Morgan Stanley Overweight → Equal-Weight $84 → $74
Dec-09-21Resumed Wells Fargo Equal Weight $72
Dec-06-21Initiated Goldman Neutral $80
Nov-19-21Upgrade BMO Capital Markets Market Perform → Outperform $72 → $85
Nov-19-21Resumed Piper Sandler Neutral $77
Oct-20-21Resumed Cowen Outperform
Jul-30-21Reiterated RBC Capital Mkts Outperform $81 → $84
Jul-30-21Reiterated BMO Capital Markets Market Perform $67 → $72
Apr-01-21Upgrade Bernstein Mkt Perform → Outperform $80
Mar-30-21Upgrade Redburn Neutral → Buy
Jan-19-21Upgrade Morgan Stanley Equal-Weight → Overweight $83
Jan-04-21Upgrade Guggenheim Neutral → Buy
Nov-03-20Resumed Morgan Stanley Equal-Weight $67
Oct-28-20Initiated UBS Neutral $61
Sep-30-20Resumed Jefferies Buy $78
Sep-15-20Upgrade Maxim Group Hold → Buy $88
Jul-31-20Reiterated Wells Fargo Equal Weight $87 → $76
Jul-31-20Reiterated SunTrust Hold $73 → $74
Jul-31-20Reiterated RBC Capital Mkts Outperform $89 → $87
Jul-31-20Reiterated Piper Sandler Overweight $90 → $85
Jan-26-22 11:11AM  
Jan-25-22 06:52PM  
06:21PM  
04:08PM  
03:01PM  
01:38PM  
Jan-24-22 05:50PM  
01:38PM  
10:30AM  
Jan-21-22 06:24PM  
01:38PM  
09:38AM  
09:38AM  
08:50AM  
Jan-20-22 05:38PM  
01:38PM  
Jan-19-22 09:38AM  
Jan-18-22 07:35PM  
05:38PM  
04:05PM  
02:02PM  
01:38PM  
01:23PM  
09:38AM  
Jan-17-22 06:00PM  
Jan-16-22 11:31AM  
Jan-14-22 04:51PM  
08:45AM  
Jan-12-22 11:10AM  
Jan-11-22 05:50PM  
02:30PM  
01:38PM  
10:35AM  
09:24AM  
Jan-10-22 01:38PM  
09:38AM  
08:30AM  
Jan-07-22 05:38PM  
Jan-06-22 09:38AM  
07:56AM  
Jan-05-22 12:10PM  
10:30AM  
Jan-04-22 01:38PM  
01:31PM  
Jan-03-22 05:50PM  
Dec-31-21 07:41AM  
Dec-30-21 09:24AM  
04:51AM  
Dec-29-21 06:00PM  
02:16PM  
11:40AM  
09:40AM  
09:15AM  
03:45AM  
Dec-28-21 03:08PM  
11:12AM  
02:38AM  
Dec-27-21 02:54PM  
Dec-24-21 11:00AM  
Dec-23-21 05:50PM  
Dec-22-21 06:00PM  
05:08PM  
11:19AM  
10:55AM  
09:16AM  
08:14AM  
Dec-21-21 07:12PM  
04:35PM  
04:05PM  
09:47AM  
04:00AM  
Dec-18-21 08:38PM  
Dec-17-21 10:43AM  
09:52AM  
09:36AM  
Dec-16-21 06:00PM  
05:50PM  
Dec-15-21 08:51AM  
Dec-14-21 09:38PM  
10:32AM  
Dec-13-21 06:17PM  
05:38PM  
02:45PM  
Dec-11-21 10:00AM  
09:00AM  
08:30AM  
Dec-10-21 05:50PM  
08:00AM  
Dec-09-21 08:51AM  
08:20AM  
Dec-08-21 07:38PM  
10:38AM  
07:43AM  
Dec-07-21 03:16PM  
10:48AM  
10:14AM  
08:45AM  
Dec-03-21 06:15AM  
Dec-01-21 08:11AM  
Nov-30-21 09:15AM  
Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of human immunodeficiency virus (HIV) infection; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr; Tizona; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos; Janssen; Japan Tobacco, Inc.; Gadeta; Bristol-Myers Squibb Company; Merck; and Novo Nordisk A/S. The company was founded in 1987 and is headquartered in Foster City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wilfong Diane E.SVP, Controller & CAOAug 17Option Exercise68.0813,610926,53634,008Aug 18 07:32 PM
Wilfong Diane E.SVP, Controller & CAOAug 17Sale72.5013,610986,72520,398Aug 18 07:32 PM
Mercier JohannaChief Commercial OfficerMay 04Sale66.0919,4961,288,5478,068May 05 05:02 PM
Whitley Richard JamesDirectorMay 03Option Exercise20.6420,282418,72251,404May 04 06:37 PM
Whitley Richard JamesDirectorMay 03Sale64.5720,2821,309,65531,122May 04 06:37 PM
Pletcher Brett AEVP,Corp Affairs & Gen CounselMar 11Sale63.361,48694,15329,166Mar 12 06:39 PM
Wilfong Diane E.SVP, Controller & CAOFeb 10Option Exercise0.00778017,606Feb 11 05:58 PM
Pletcher Brett AEVP,Corp Affairs & Gen CounselFeb 10Sale67.411,975133,13528,832Feb 11 05:56 PM
Wilfong Diane E.SVP, Controller & CAOFeb 06Option Exercise0.001,866017,361Feb 09 07:46 PM
Pletcher Brett AEVP,Corp Affairs & Gen CounselFeb 06Option Exercise0.002,728031,560Feb 09 07:44 PM
Dickinson Andrew DEVP, Chief Financial OfficerFeb 06Option Exercise0.001,818033,081Feb 09 07:41 PM
Pletcher Brett AEVP,Corp Affairs & Gen CounselFeb 01Sale65.979,711640,63328,832Feb 03 06:23 PM